Clobetasol propionate foam 0.05%: a novel vehicle with enhanced delivery.
Franz
T J
TJ
Connetics Corporation, Palo Alto, CA, USA. frnaz_t@connetics.com
Parsell
D A
DA
Myers
J A
JA
Hannigan
J F
JF
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002990:Clobetasol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D016503:Drug Delivery Systems; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D014677:Pharmaceutical Vehicles; D011565:Psoriasis / Q000188:drug therapy*; D012536:Scalp Dermatoses / Q000188:drug therapy*; D012996:Solutions; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014677:Pharmaceutical Vehicles; D012996:Solutions; D002990:Clobetasol